Back

SGLT2 inhibitors prevent mortality and CTRCD in anthracycline-treated patients: first meta-analytic evidence integrating EMPACARD trial

20 June 2026 (15:03 - 15:15)
Organised by: Logo
Congress Presentation Part of: Diagnosis and early management of cancer therapy–related cardiotoxicity Diagnosis and Management of Cardiovascular Disease in Patients with Cancer Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Mr Anchit Chauhan

New Delhi (India)

3 More presentations in this session

Presentation thumbnail
Troponin to detect major cardiovascular adverse events on immune checkpoint inhibitors : a propensity matched multicentre retrospective study
Doctor I. Hamdi (Paris, FR)
Abstract Slides
Presentation thumbnail
Mitochondrial imaging detects early cardiac responses to cancer immunotherapy
Doctor J. Levi (San Francisco, US)
Abstract Slides Video
Presentation thumbnail
Screening for atrial fibrillation in cancer: a randomised controlled clinical trial (SARIC)
Doctor Z. Asad (Oklahoma City, US)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and early management of cancer therapy–related cardiotoxicity
Video

The Event

Event poster

ESC Cardio-Oncology 2026

20 June 2026 15:03 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources